Radiation Therapy Field Extent for Adjuvant Treatment of Axillary Metastases From Malignant Melanoma

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1376-1382

  Beadle, Beth M ^a   Guadagnolo, B Ashleigh ^a   Ballo, Matthew T ^a   Lee, Jeffrey E ^a   Gershenwald, Jeffrey E ^a   Cormier, Janice N ^a   Mansfield, Paul F ^a   Ross, Merrick I ^a   Zagars, Gunar K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Axillary lymph nodes; Malignant melanoma; Radiation; Supraclavicular lymph nodes

Indexed keywords

BODY FLUIDS; DECISION MAKING; MULTIVARIANT ANALYSIS; PATHOLOGY; PATIENT MONITORING; RADIATION; RADIOTHERAPY;

ADJUVANT TREATMENTS; AXILLARY LYMPH NODES; CONTROL RATES; DISEASE-FREE SURVIVALS; DISTANT METASTASIS; MALIGNANT MELANOMA; MEDICAL RECORDS; MULTI-VARIATE ANALYSIS; OVERALL SURVIVALS; POSTOPERATIVE RADIATION THERAPIES; RADIATION FIELDS; RADIATION THERAPIES; SUPRACLAVICULAR LYMPH NODES; SURVIVAL RATES; UNIVARIATE;

DISEASE CONTROL;

CYTOTOXIC AGENT; IMMUNOLOGIC AGENT;

ADULT; AGED; ARTICLE; AXILLA; AXILLARY LYMPH NODE METASTASIS; BRACHIAL PLEXUS NEUROPATHY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FIBROSIS; FOLLOW UP; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MULTIVARIATE ANALYSIS; NEUROPATHY; OVERALL SURVIVAL; PERIPHERAL EDEMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION INJURY; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; RIB FRACTURE; SURVIVAL RATE; SYSTEMIC THERAPY; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AXILLA; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 62649143727     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1910     Document Type: Article

References (21)

1. Lens M.B., and Dawes M. Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials. J Clin Oncol 20 (2002) 1818-1825
2. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14 (1996) 7-17
3. Kirkwood J.M., Ibrahim J.G., Sosman J.A., et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol 19 (2001) 2370-2380
4. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 12 (1986) 867-872
5. Habermalz H.J., and Fischer J.J. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer 38 (1976) 2258-2262
6. Sause W.T., Cooper J.S., Rush S., et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20 (1991) 429-432
7. Geara F.B., and Ang K.K. Radiation therapy for malignant melanoma. Surg Clin North Am 76 (1996) 1383-1398
8. Ballo M.T., Strom E.A., Zagars G.K., et al. Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 52 (2002) 964-972
9. Calabro A., Singletary S.E., and Balch C.M. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 124 (1989) 1051-1055
10. Byers R.M. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch Surg 121 (1986) 1338-1341
11. Lee R.J., Gibbs J.F., Proulx G.M., et al. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 46 (2000) 467-474
12. O'Brien C.J., Coates A.S., Petersen-Schaefer K., et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 162 (1991) 310-314
13. Harris E.K., and Albert A. Survivorship analysis for clinical studies (1991), Marcel Dekker, New York
14. Altman D.G. Practical statistics for medical research (1991), Chapman and Hall, London
15. Barranco S.C., Romsdahl M.M., and Humphrey R.M. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 31 (1971) 830-833
16. Dewey D.L. The radiosensitivity of melanoma cells in culture. Br J Radiol 44 (1971) 816-817
17. Burmeister B.H., Mark Smithers B., Burmeister E., et al. A prospective Phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol 81 (2006) 136-142
18. Stevens G., Thompson J.F., Firth I., et al. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 88 (2000) 88-94
19. Ballo M.T., Garden A.S., Myers J.N., et al. Melanoma metastatic to cervical lymph nodes: can radiotherapy replace formal dissection after local excision of nodal disease?. Head Neck 27 (2005) 718-721
20. Ballo M.T., and Ang K.K. Radiotherapy for cutaneous malignant melanoma: rationale and indications. Oncology (Williston Park) 18 (2004) 99-107 discussion 107-110, 113-104
21. Chang D.T., Amdur R.J., Morris C.G., et al. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 66 (2006) 1051-1055